COVID BIOPHARMA LIMITED
Company number 12570359 · Monitor this company
The most recent accounts indicate this company is dormant and not trading.
Executive summary
COVID BIOPHARMA LIMITED is currently a dormant entity with minimal financial resources and no trading activity, representing a high risk from a solvency and liquidity perspective. While regulatory compliance is maintained and the board comprises relevant professionals, the absence of operational data raises concerns about sustainability. Further due diligence should focus on the company’s strategic plans and any undisclosed liabilities or assets.
Shareholders' funds
£100
Balance sheet as at 2024-12-31
What it does
The principal activity of the company is research and experimental development on biotechnology
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-04-23
- Registered office
- 1st Floor 40-44, Newman Street, London, England, W1T 1QD
- Postcode
- W1T 1QD
- Capital
- 100 USD
- Accounts category
- Dormant
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-04-22
- Next due by
- 2027-05-06
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 5 current
Competitors London
This company ranks 85 among research and experimental development on biotechnology in London.
The class of 2020
41%
of the 596 companies in this sector incorporated in 2020 are still active today; 54% have since been dissolved.
A fact about the year, not a forecast for this company.